Effectiveness of a Natural Cream (STRETCH MARKS B GONE) in Reducing Stretch Marks

An Open-Label Exploratory Study on the Efficacy of a Multi-Ingredient Natural Topical Formulation STRETCH MARKS B GONE for the Management of Stretch Marks (Striae Distensae) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096476

Enrollment

Registered

2025-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L906- Striae atrophicae

Interventions

Intervention1: Stretch Marks B Gone: Beeswax,Shea butter,Coconut oil,Moringa Oil,Jojoba oil, Almond oil,Evening Primrose oil,Vit E oil and Frankinsence oil Study duration - 4 weeks each participant C

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults 18–45 years. 2. Visible stretch marks (striae rubra or alba) on belly/hips/thighs/knees and shoulders, present Greater than or equal to 3 months to 1 years due to change in the body weight, Post Partum Changes. 3. Willing to refrain from other topical treatments/procedures on test areas during the study. 4. Able to comply and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding. 2. Known allergy to any ingredient of test product. 3. Recent Greater than or equal to 3 topical retinoid, steroid, or procedural treatment on target areas. 4. Active dermatitis or infection in test area. 5. Participation in another clinical study within 30 days.

Design outcomes

Primary

Measure	Time frame
Mean change from baseline, Week 2 and Week 4 in photo graded Visual Improvement Scale (VIS) and or percent change in stretch-marks. (For those who give consent)Timepoint: Baseline (Day 0), Visit 2 (week 2), Visit 3 (28 days)	—

Secondary

Measure	Time frame
1. Skin texture: Mean percentage improvement - baseline and Week 4 (target: approx 25 percent improvement). Report mean ± SD and CI. (instrument plus Self-assessment) 2. Dryness or tightness: Proportion of participants demonstrating self-perceived improvement and an increase in skin hydration as measured by a corneometer at baseline and Week 4. 3. Elasticity (Cutometer): Mean percentage change in R2 at Week 4 (target approx 15 percent) Baseline & week 4 4. VAS – Tightness, dryness, and itching (0–10) – Baseline, Week 2 and Week 4 5. 5-point Likert for agreement with statements (e.g., elastic or comfortable). Week 4 6. DLQI – Dermatology Life Quality Index (Baseline and week 4) 7. Safety: number and percentage of subjects with local irritation or other AEs.Timepoint: Baseline (Day 0), Visit 2 (week 2), Visit 3 (28 days)	—

Measure

Time frame

1. Skin texture: Mean percentage improvement - baseline and Week 4 (target: approx 25 percent improvement). Report mean ± SD and CI. (instrument plus Self-assessment) 2. Dryness or tightness: Proportion of participants demonstrating self-perceived improvement and an increase in skin hydration as measured by a corneometer at baseline and Week 4. 3. Elasticity (Cutometer): Mean percentage change in R2 at Week 4 (target approx 15 percent) Baseline & week 4 4. VAS – Tightness, dryness, and itching (0–10) – Baseline, Week 2 and Week 4 5. 5-point Likert for agreement with statements (e.g., elastic or comfortable). Week 4 6. DLQI – Dermatology Life Quality Index (Baseline and week 4) 7. Safety: number and percentage of subjects with local irritation or other AEs.Timepoint: Baseline (Day 0), Visit 2 (week 2), Visit 3 (28 days)

—

Countries

India

Contacts

Public ContactDr Gayathri Sivakumar

DK Elite Health Care Centre

saheerose@gmail.com09843591097

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026